Literature DB >> 16751406

C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors.

Carolyn Mold1, Terry W Du Clos.   

Abstract

Streptococcus pneumoniae is the most common organism responsible for community acquired pneumonia and meningitis. In pneumococcal pneumonia, a strong local inflammatory cytokine response reduces the frequency of bacteremia and increases survival. The initiation of this cytokine response by innate recognition of bacterial cell wall components through TLR has been described, but the role of soluble innate mediators has received limited attention. C-reactive protein (CRP) is an acute phase protein that binds phosphocholine residues on S. pneumoniae cell walls. CRP interacts with phagocytic cells through FcgammaRI and FcgammaRII and activates the classical complement pathway. CRP is protective in mouse pneumococcal bacteremia by increasing complement-dependent clearance and killing of bacteria. We studied the cytokine response of PBMC stimulated with CRP-opsonized S. pneumoniae to determine the effect of CRP interaction with FcgammaR. CRP dramatically increased the production of TNF-alpha and IL-1beta in response to S. pneumoniae. These increases were blocked by phosphocholine, which inhibits CRP binding to S. pneumoniae, by inhibitors of FcgammaR signaling, and by mAb to FcgammaRI and FcgammaRII. A mutated rCRP with decreased FcgammaR binding had a decreased ability to stimulate TNF-alpha release, compared with wild-type CRP. Individuals who were homozygous for the R-131 allele of FcgammaRIIA, which has a higher affinity for CRP, showed higher responses to CRP-opsonized bacteria than did individuals homozygous for the H-131 allele, further implicating this receptor. The results indicate that CRP recognition of S. pneumoniae and binding to FcgammaR may enhance the early protective cytokine response to infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751406     DOI: 10.4049/jimmunol.176.12.7598

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Pneumococci: immunology of the innate host response.

Authors:  Gavin K Paterson; Carlos J Orihuela
Journal:  Respirology       Date:  2010-07-20       Impact factor: 6.424

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.

Authors:  F Liu; H Y Chen; X R Huang; A C K Chung; L Zhou; P Fu; A J Szalai; H Y Lan
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

4.  Serum amyloid A protects murine macrophages from lethal toxin-mediated death.

Authors:  Kira Rose; Paul Long; Malini Shankar; Jimmy D Ballard; Carol F Webb
Journal:  Cell Immunol       Date:  2011-10-29       Impact factor: 4.868

5.  Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.

Authors:  Jinghua Lu; Kristopher D Marjon; Lorraine L Marnell; Ruipeng Wang; Carolyn Mold; Terry W Du Clos; Peter Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

6.  The Lung-Liver Axis: A Requirement for Maximal Innate Immunity and Hepatoprotection during Pneumonia.

Authors:  Kristie L Hilliard; Eri Allen; Katrina E Traber; Kazuko Yamamoto; Nicole M Stauffer; Gregory A Wasserman; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

Review 7.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

8.  C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis.

Authors:  Lin Zhang; Shan-Hui Liu; Tyler T Wright; Zhi-Yuan Shen; Hai-Yun Li; Wei Zhu; Lawrence A Potempa; Shang-Rong Ji; Alexander J Szalai; Yi Wu
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

9.  Activation of Hepatic STAT3 Maintains Pulmonary Defense during Endotoxemia.

Authors:  Kristie L Hilliard; Eri Allen; Katrina E Traber; Yuri Kim; Gregory A Wasserman; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

10.  FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.

Authors:  Hervé Ghesquières; Beth R Larrabee; Corinne Haioun; Brian K Link; Aurélie Verney; Susan L Slager; Nicolas Ketterer; Stephen M Ansell; Richard Delarue; Matthew J Maurer; Olivier Fitoussi; Thomas M Habermann; Fréderic Peyrade; Ahmet Dogan; Thierry J Molina; Anne J Novak; Hervé Tilly; James R Cerhan; Gilles Salles
Journal:  Hematol Oncol       Date:  2016-06-10       Impact factor: 5.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.